Physician profile
Melissa Baylor
NPI 1205851219
$6,739.59
in general payments reported to CMS, 2019-2025
36 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,390 · 2020: $545 · 2021: $568 · 2022: $1,064 · 2023: $1,050 · 2024: $1,072 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,141 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,140.56 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,270.87 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $1,129.98 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Abbvie INC. | $979.61 | 2019-2025 | Ubrelvy, Viberzi, Linzess |
| Pfizer INC. | $480.16 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $423.08 | 2019-2024 | Xarelto |
| Lilly USA, LLC | $401.66 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $251.68 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.41 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $219.32 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Sanofi Pasteur INC. | $142.69 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $140.46 | 2019-2024 | Camzyos, Eliquis |
| Takeda Pharmaceuticals U.S.A., INC. | $137.73 | 2019-2025 | Trintellix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.66 | 2019-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $85.08 | 2019-2024 | |
| Astellas Pharma US INC | $83.49 | 2024-2025 | Veozah |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $64.94 | 2019-2025 | Evenity |
| Teva Pharmaceuticals USA, INC. | $60.70 | 2019-2020 | |
| Amarin Pharma, INC. | $59.70 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.06 | 2022-2024 | |
| Dexcom, INC. | $54.34 | 2023-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $44.96 | 2023-2024 | Freestyle Libre, Freestyle Libre 3 |
| Exact Sciences Corporation | $33.50 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $31.96 | 2019-2020 | |
| Seqirus USA INC | $27.49 | 2025 | Flucelvax, Fluad |
| Phathom Pharmaceuticals, INC. | $26.80 | 2024 | Voquezna |
| Viatris Specialty LLC | $25.66 | 2025 | Yupelri |
| Biohaven Pharmaceutical Holding Company LTD. | $21.97 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $18.10 | 2024 | Rexulti |
| Idorsia Pharmaceuticals US INC | $17.48 | 2022 | |
| Axsome Therapeutics, INC. | $16.62 | 2024 | Auvelity |
| Ibsa Pharma INC. | $16.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.99 | 2019 | |
| Ironshore Pharmaceuticals INC. | $14.78 | 2019 | |
| Allergan, INC. | $13.13 | 2020 | |
| Mannkind Corporation | $12.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Baylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.